Nancy Dgetluck

811 citations

25 papers · 608 indexed · h-index 11

Impact in

Biological Psychiatry top 10%
Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Cholinesterase and Neurodegenerative Diseases

Papers in ⓘ

Dermatology 4
- Skin Diseases and Diabetes 2
Psychiatry and Mental health 6
- Bipolar Disorder and Treatment 2
- Schizophrenia research and treatment 2

Co-authors: Dana Hilt (9 shared papers)Maria S. Gawryl (7 shared papers)Richard S.E. Keefe (4 shared papers)Michael G. Palfreyman (2 shared papers)Sheldon Preskorn (1 shared paper)Lance O. Bauer (1 shared paper)Hans J. Moebius (3 shared papers)Gerhard Koenig (2 shared papers)
Journals: Annals of the Rheumatic Diseases (10 papers)Alzheimer s & Dementia (3 papers)Schizophrenia Research (2 papers)Urology (1 paper)Clinical and Experimental Rheumatology (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

Nancy Dgetluck

24 papers receiving 590 citations

Peers

Countries citing papers authored by Nancy Dgetluck

Since Specialization

Citations

This map shows the geographic impact of Nancy Dgetluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Dgetluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Dgetluck more than expected).

Fields of papers citing papers by Nancy Dgetluck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Dgetluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Dgetluck. The network helps show where Nancy Dgetluck may publish in the future.

Co-authors

The 25 scholars most cited alongside Nancy Dgetluck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nancy Dgetluck Line = papers co-authored together Nancy Dgetluck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia Neuropsychopharmacology ·Richard S.E. Keefe, Herbert Meltzer, Nancy Dgetluck, Maria S. Gawryl, Gerhard Koenig, Hans J. Moebius, Ilise Lombardo, Dana Hilt	2015	120
2	Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition Journal of Psychiatric Practice ·Sheldon Preskorn, Maria S. Gawryl, Nancy Dgetluck, Michael G. Palfreyman, Lance O. Bauer, Dana Hilt	2014	107
3	Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis Arthritis & Rheumatology ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Robert Lafyatis, Viktor Martyanov, Tammara Wood, Michael L. Whitfield, S. Constantine, Elizabeth Lee, Nancy Dgetluck, Barbara White	2020	72
4	Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis Journal of Cystic Fibrosis ·James F. Chmiel, Patrick A. Flume, D.G. Downey, Allen J. Dozor, Carla Colombo, Henryk Mazurek, Ewa Sapiejka, Marta Rachel, S. Constantine, Brian Conley, Nancy Dgetluck, Quinn Dinh, Barbara White, J.S. Elborn	2020	58
5	Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale European Neuropsychopharmacology ·Richard S.E. Keefe, Vicki G. Davis, Nathan B. Spagnola, Dana Hilt, Nancy Dgetluck, Stacy A. Ruse, T. D. Patterson, Meera Narasimhan, Philip D. Harvey	2014	48
6	Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies Clinical Therapeutics ·Ann Barbier, Henk W. M. Hilhorst, André van Vliet, Peter J. Snyder, Michael G. Palfreyman, Maria S. Gawryl, Nancy Dgetluck, Monica Massaro, Renger G. Tiessen, Wia Timmerman, Dana Hilt	2014	39
7	Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial Journal of Investigative Dermatology ·Victoria P. Werth, Emily Z. Hejazi, S.M. Peña, Jessica S. Haber, Majid Zeidi, Nithin Reddy, Joyce Okawa, Rui Feng, Muhammad M. Bashir, Kirubel Gebre, Arvin Jadoo, Josef Symon S. Concha, Nancy Dgetluck, S. Constantine, Barbara White	2022	37
8	Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial Urology ·Evan R. Goldfischer, John J. Kowalczyk, William R. Clark, Erin Brady, Michael Shane, Nancy Dgetluck, Suzanne Klise	2012	25
9	FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis Annals of the Rheumatic Diseases ·Victoria P. Werth, Emily Z. Hejazi, S.M. Peña, J Háber, Joyce Okawa, Ru Feng, K. Gabre, Josef Concha, C. Cornwall, Nancy Dgetluck, S. Constantine, Barbara White	2018	16
10	A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale Clinical and Experimental Rheumatology ·Robert Spiera, Dinesh Khanna, Masataka Kuwana, Daniel E. Furst, Tracy Frech, Laura K. Hummers, Wendy Stevens, Marco Matucci‐Cerinic, Murray Baron, Oliver Distler, Nancy Dgetluck, Bradley J. Bloom, Quinn Dinh, Barbara White, Christopher P. Denton	2021	14
11	Circadian rhythms in cognitive functioning among patients with schizophrenia: Impact on signal detection in clinical trials of potential pro-cognitive therapies Schizophrenia Research ·Michael R. Hufford, Vicki G. Davis, Dana Hilt, Nancy Dgetluck, Yona Geffen, Antony Loebel, George M. Haig, Luca Santarelli, Richard S.E. Keefe	2014	13
12	Statistical Methods for Analyzing Discrete Responses of Insects Tested Repeatedly Environmental Entomology ·Edward J. Stanek, Scott R. Diehl, Nancy Dgetluck, Maura E. Stokes, Ronald J. Prokopy	1987	10
13	SAT0512 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated in an open label extension of trial jbt101-dm-001 Annals of the Rheumatic Diseases ·Victoria P. Werth, Basil Patel, Josef Concha, Joyce Okawa, David R. Pearson, Emily Z. Hejazi, Ruofei Feng, C. Cornwall, Nancy Dgetluck, S. Constantine, Arun Aggarwal, Barbara White	2018	8
14	OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC) Annals of the Rheumatic Diseases ·Robert Spiera, Masataka Kuwana, Dinesh Khanna, Laura K. Hummers, Tracy Frech, Wendy Stevens, Jessica Gordon, Suzanne Kafaja, Marco Matucci‐Cerinic, Oliver Distler, E. B. Lee, Yael Levy, Jae‐Bum Jun, S. Constantine, Nancy Dgetluck, Barbara White, D. Furst, Christopher P. Denton	2021	8
15	SAT0303 DESIGN OF PHASE 3 STUDY OF LENABASUM FOR THE TREATMENT OF DERMATOMYOSITIS Annals of the Rheumatic Diseases ·Victoria P. Werth, Chester V. Oddis, Ingrid E. Lundberg, David Fiorentino, C. Cornwall, Nancy Dgetluck, S. Constantine, Barbara White	2019	7
16	OP0006 Safety and efficacy of lenabasum (JBT-101) in diffuse cutaneous systemic sclerosis subjects treated for one year in an open-label extension of trial jbt101-ssc-001 Annals of the Rheumatic Diseases ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, D.E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Eunyoung Lee, Nancy Dgetluck, S. Constantine, Barbara White	2018	6
17	P3–285: Validation of a novel cognitive composite assessment for mild and prodromal Alzheimer's disease Alzheimer s & Dementia ·John Harrison, Nancy Dgetluck, Maria S. Gawryl, Hans J. Moebius, Dana Hilt	2013	5
18	O4‐12‐04: EVP‐6124, a selective alpha‐7 partial agonist, has positive effects on cognition and clinical function in mild‐to‐moderate Alzheimer's disease patients: Results of a six‐month, double‐blind, placebo controlled, dose ranging study Alzheimer s & Dementia ·Dana Hilt, Maria S. Gawryl, Gerhard Koenig, Nancy Dgetluck, Hans J. Moebius	2012	4
19	OP0325 SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC) Annals of the Rheumatic Diseases ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robin Domsic, Vivian Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Elizabeth Lee, S. Constantine, Nancy Dgetluck, Barbara White	2019	3
20	OP0241 SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY OF LENABASUM IN REFRACTORY SKIN-PREDOMINANT DERMATOMYOSITIS (DM) SUBJECTS Annals of the Rheumatic Diseases ·Victoria P. Werth, David R. Pearson, Joyce Owaka, Rui Feng, Josef Concha, Basil Patel, Emily Z. Hejazi, C. Cornwall, S. Constantine, Nancy Dgetluck, Barbara White	2019	3

About Nancy Dgetluck

Nancy Dgetluck is a scholar working on Dermatology, Psychiatry and Mental health, Pathology and Forensic Medicine, Urology and Pharmacology, having authored 25 papers that have together received 608 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Bipolar Disorder and Treatment (2 papers), Schizophrenia research and treatment (2 papers), Skin Diseases and Diabetes (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Biological Psychiatry (51 citations), Pharmacology (174 citations), Psychiatry and Mental health (146 citations), Dermatology (49 citations) and Cellular and Molecular Neuroscience (94 citations). Nancy Dgetluck has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Dana Hilt, Maria S. Gawryl, Richard S.E. Keefe, Michael G. Palfreyman, Sheldon Preskorn, Lance O. Bauer, Hans J. Moebius, Gerhard Koenig, Barbara White and S. Constantine. Their work appears in journals such as Annals of the Rheumatic Diseases, Alzheimer s & Dementia, Schizophrenia Research, Urology and Clinical and Experimental Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact